Kiniksa Pharmaceuticals International

KNSANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.935 B

$76.06 -0.59%

Close of 7 Aug 2026

Revenue

$677.6M

#1756 by revenue

Earnings

$59.0M

#1509 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

100.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#52Ptc TherapeuticsPTCT$6.12B
#53Dianthus TherapeuticsDNTH$6.09B
#54Kiniksa Pharmaceuticals InternationalKNSA$5.93B
#55Ligand PharmaceuticalsLGND$5.88B
#56Amneal PharmaceuticalsAMRX$5.79B

Where these numbers come from

Share counts and financials for Kiniksa Pharmaceuticals International are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.